-
Cheap malaria vaccine developed with help of Oxford scientists approved for global rollout | World News
admin
The World Health Organisation (WHO) has approved a low-cost, readily available vaccine for malaria that promises to help ease one of the greatest disease burdens on the developing world. The R21 vaccine, developed by the University of Oxford, the Serum Institute of India and drug maker Novavax, could help reduce the 500,000 malaria-associated deaths that…
-
Ghana becomes first country to approve Oxford malaria vaccine R21/Matrix-M | World News
admin
Ghana has become the first country in the world to approve a new malaria vaccine developed by Oxford University. R21/Matrix-M was shown to be up to 80% effective in a trial involving 400 children in Burkina Faso, published in September. Malaria kills more than 600,000 people each year, most of them children in Africa, and…
-
New malaria vaccine could cut deaths by 70% by 2030, British scientists say | World News
admin
A new vaccine could reduce deaths from malaria by 70% by 2030, according to British scientists who developed it. The prediction was made after clinical trials in Africa showed the vaccine, called R21/Matrix-M, was highly effective at protecting children, who bear the brunt of the mosquito-borne disease. Results will be filed with the World Health…